Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Labs drops on missing Q1 profit view

** Divi's Laboratories DIVI.NS drops 3% to 6,220 rupees; top loser on pharma index .NIPHARM, which is down 1.3%

** Drugmaker misses Q1 profit view on weak U.S. pricing for its drugs amid stiff competition

** Stock slumped as much as 4% after results; was down 2.5% ahead of results

** Stock rated "hold" on avg; median PT is 6,460 rupees, per data compiled by LSEG

** YTD, DIVI gains 2% vs NIPHARM's 7.4% decline

 (Reporting by Kashish Tandon in Bengaluru)

 ((Kashish.tandon@thomsonreuters.com))

Recent news on Divi's Laboratories

See all news